Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Rev. chil. enferm. respir ; 32(3): 160-168, set. 2016. tab
Article in Spanish | LILACS | ID: biblio-844378

ABSTRACT

This paper presents clinical experience with Omalizumab treatment in 8 pediatric patients in Chile. All children presented difficult to control asthma despite receiving high intensity treatment, with low quality of life. All patients were studied in order to discard errors in asthma diagnosis and to evaluate asthma treatment adherence and inhalation technique. After evaluation, patients proven to have severe therapy resistant asthma were indicated treatment with Omalizumab. Significant clinical improvement was observed, with reduced asthma symptoms and number of exacerbations, as well as an improved quality of life. Omalizumab showed a good safety profile with mild and transient adverse reactions in 6 administrations of a total of 122.


Se presenta la experiencia clínica con el uso de Omalizumab en 8 pacientes pediátricos en nuestro país. Todos los pacientes presentaban asma sin control a pesar de recibir terapia de alta intensidad, asociado a una muy deficiente calidad de vida. La totalidad de los pacientes fueron sometidos en cada centro a un estudio exhaustivo para poder descartar error en el diagnóstico y se evaluó la adherencia y la técnica inhalada. Al comprobarse que estos pacientes tenían asma severo resistente a tratamiento se indicó Omalizumab, el cual produjo una mejoría clínica significativa. Se observó una reducción de las exacerbaciones y de los síntomas de asma acompañado de una mejoría de la calidad de vida, asociado a un buen perfil de seguridad. Se observaron reacciones adversas leves y transitorias en 6 administraciones de un total de 122.


Subject(s)
Humans , Male , Female , Child , Adolescent , Anti-Asthmatic Agents/therapeutic use , Asthma/drug therapy , Omalizumab/therapeutic use , Asthma/physiopathology , Chile , Clinical Evolution , Quality of Life , Treatment Outcome
2.
Rev. Méd. Clín. Condes ; 23(4): 484-491, jul. 2012. ilus, tab
Article in Spanish | LILACS | ID: biblio-1145420

ABSTRACT

Aunque pueda parecer paradójico, las inmunodeficiencias primarias y la secundaria a infección por VIH frecuentemente se complican con enfermedades autoinmunes. Esto debido a la desregulación del sistema inmune y a la activación policlonal debida a infecciones recurrentes. Se revisan diversas enfermedades autoinmunes y autoanticuerpos asociados con ambos tipos de inmunodeficiencias. Las enfermedades autoinmunes pueden ser la primera manifestación de una inmunodeficiencia, por lo que deben estudiarse especialmente si la enfermedad autoinmune es atípica. Las patologías más frecuentemente asociadas son las citopenias autoinmunes y los enfermedades reumatológicas. Debe realizarse una exclusión completa de las infecciones coincidentes o posiblemente causantes de complicaciones autoinmunes antes de iniciar tratamientos específicos para ellas.


Although it may seem paradoxical, primary immunodeficiencies and HIV immunodeficiency are frecuently complicated by autoimmune conditions. This is because of the immune system disregulation and polyclonal activation due to recurrent infections. We review various autoimmune diseases and autoantibodies associated with both types of immunodeficiencies. Autoimmune diseases my be the first manifestation of an immunodeficiency, so we should screen for it, specially if this autoimmune disease is atypical. The most frecuent disease associated with immunodeficiencies are autoimmune cytopenias and rheumatologic disorders. A through exclusion of infections coincident with or possibly causative of autoimmune complication should be undertaken before initiating specific treatments for autoimmune disease in this patients.


Subject(s)
Humans , Immunologic Deficiency Syndromes/diagnosis , Immunologic Deficiency Syndromes/epidemiology , Autoimmune Diseases/diagnosis , Autoimmune Diseases/epidemiology , HIV/immunology
3.
Rev. méd. Chile ; 135(12): 1566-1571, dic. 2007. tab
Article in Spanish | LILACS | ID: lil-477987

ABSTRACT

Background: Immunotherapy can be used to treat allergic reactions to insect stings, specially bees and wasps. Aim: To report the experience with immunotherapy with aqueous extracts of hymenoptera venoms (bees and wasps). Material and methods: Ten patients aged 6 to 58 years were treated in an allergy center of a University Clinical Hospital. The medical indication for this treatment was, in all patients, anaphylactic reactions after hymenoptera stings. Immunotherapy was carried out using standardized vaccines (Aqueous extracts Venomvac LETI, Spain), applied in a traditional protocol, with subcutaneous injections. This protocol had two phases: a buildup phase (between weeks 1 and 13) and a monthly maintenance phase, from the 13th week. The monthly maintenance dose was 100 fig of hymenoptera specific venom extract. Results: Six patients had adverse reactions of different severity, during the treatment protocols and all had a good response to immediate therapeutic measures. After these events, they followed the protocol without problems. Two patients, treated with bee vaccines, suffered an accidental bee sting during the maintenance phase and they developed only local reactions. Conclusions: The lack of adverse reactions to bee stings in these two patients indicates the acquisition of clinical tolerance.


Subject(s)
Adolescent , Adult , Animals , Child , Female , Humans , Male , Middle Aged , Bee Venoms/therapeutic use , Desensitization, Immunologic/methods , Hymenoptera/immunology , Hypersensitivity, Immediate/therapy , Insect Bites and Stings/therapy , Wasp Venoms/therapeutic use , Anaphylaxis/therapy , Bee Venoms/adverse effects , Bee Venoms/immunology , Hypersensitivity, Immediate/immunology , Insect Bites and Stings/complications , Insect Bites and Stings/immunology , Wasp Venoms/adverse effects , Wasp Venoms/immunology
4.
Rev. méd. Chile ; 134(4): 475-480, abr. 2006. ilus, tab
Article in Spanish | LILACS | ID: lil-428548

ABSTRACT

Antineutrophil cytoplasmic antibody (ANCA)-positive vasculitis is an uncommon complication of the use of propylthiouracil. When it occurs, it affects multiple organs as any systemic vasculitis. We report three females and one male, aged 30, 40, 43 and 41 years respectively, that after a lapse of 12 to 28 months of propylthiouracil use, presented clinical signs of vasculitis. All had high titers of ANCA against myeloperoxidase. In three patients, a skin biopsy confirmed the diagnosis. The condition subsided when propylthiouracil was discontinued, but one female patient required the use of prednisone.


Subject(s)
Adult , Female , Humans , Male , Antibodies, Antineutrophil Cytoplasmic/drug effects , Antithyroid Agents/adverse effects , Propylthiouracil/adverse effects , Vasculitis/chemically induced , Antibodies, Antineutrophil Cytoplasmic/blood , Antithyroid Agents/therapeutic use , Biomarkers/blood , Biopsy , Hyperthyroidism/drug therapy , Propylthiouracil/therapeutic use , Vasculitis/blood , Vasculitis/pathology
5.
Rev. méd. Chile ; 133(3): 273-278, mar. 2005. graf
Article in Spanish | LILACS | ID: lil-404882

ABSTRACT

Background: Systemic vasculitis are a group of heterogeneous diseases characterized by inflammation and necrosis of blood vessel walls. The etiology is not known, but geographic and environmental factors are implicated. Aim: To describe the clinical features of microscopic polyangiitis (MPA) and Wegener's granulomatosis (WG) in a Chilean cohort of patients. Patients and methods: Retrospective review of the medical records of 123 patients with the diagnosis of systemic vasculitis (65 MPA and 58 WG), seen from 1990 to 2001. The diagnosis were made based on the American College of Rheumatology and Chapel Hill criteria. Results: The mean follow-up for MPA was 15 months (1-120) and for WG, 20 months (1-120). The median age (years) at diagnosis for MPA was 61 (19-82) and WG 50 (20-82). Gender distribution was similar in both groups (male: 68percent and 57percent respectively).The main clinical features in the MPA group were renal involvement (68percent), peripheral nervous system involvement (57percent), pulmonary hemorrhage (28percent), and skin disease (32percent). In the WG group were alveolar hemorrhage (62percent), renal involvement (78percent), paranasal sinus involvement (57percent), and ocular disease (26percent). In both, creatinine levels above 2.0 mg/dl were associated with a higher mortality (p< 0.01). ANCA by immunofluorescence was performed in 56 MPA patients (75percent had pANCA, 4percent had cANCA and 21percent were ANCA negative) and in 55 WG patients (17percent had pANCA, 79percent had cANCA and 4percent were ANCA negative). Global mortality was 18percent and 17percent respectively, and the most common causes of death were infections. Conclusions: The clinical features of our patients are similar to other published data. In our WG and MPA patients the main predictor for death was a serum creatinine above 2 mg/dl.


Subject(s)
Adult , Male , Humans , Female , Middle Aged , Granulomatosis with Polyangiitis/complications , Granulomatosis with Polyangiitis/immunology , Granulomatosis with Polyangiitis/pathology , Polyarteritis Nodosa/complications , Polyarteritis Nodosa/immunology , Polyarteritis Nodosa/pathology , Chile , Follow-Up Studies
8.
Rev. méd. Chile ; 131(3): 303-308, mar. 2003. ilus, tab, graf
Article in Spanish | LILACS | ID: lil-342318

ABSTRACT

We report a 11 years old male diagnosed as a X-linked hyper-IgM syndrome that presented with recurrent infections and sclerosing cholangitis and later developed a gallbladder cancer. Immunological evaluation showed decreased levels of serum IgG and IgA with elevated levels of IgM. Study of CD40 ligand expression on mitogen activated peripheral blood mononuclear cells revealed total absence of this marker on T lymphocytes. Molecular analysis detected, in the patient and his mother, a nonsense mutation in exon 1 of the transmembrane segment of the CD40 ligand. He also presented elevation of alkaline phosphatases and mild elevation of liver enzymes. Liver biopsy demonstrated the presence of idiopathic sclerosing cholangitis. The patient was started on monthly IVIG therapy at 400 mg/kg, as well as ursodeoxycholic acid and vitamin E, with normalization of his IgG and IgM levels a decrease in the incidence of infections and normalization of liver function. Three years after diagnosis, we detected the presence of polyps inside the gallbladder that were reported at biopsy as adenocarcinoma. He underwent hepatic bisegmentectomy (VI B-V) and local lymphadenectomy


Subject(s)
Humans , Male , Adolescent , Cholangitis, Sclerosing , Agammaglobulinemia , Gallbladder Neoplasms , Cholangitis, Sclerosing , Immunologic Deficiency Syndromes/complications
9.
Rev. méd. Chile ; 129(6): 653-9, jun. 2001. tab
Article in Spanish | LILACS | ID: lil-295395

ABSTRACT

Background: The diagnostic profile of patients with rheumatic diseases admitted to a general hospital is variable. Aim: To report the epidemiological profile of patients with rheumatic diseases admitted to a tertiary care hospital. Material and methods: All admissions to a Medicine ward of a general hospital and seen by the Rheumatology team were prospectively registered during one year in 1999. Patients were classified as primarily admitted for a rheumatic disease or admitted for other cause that required a consultation with the Rheumatology team. Results: One hundred forty five admissions due to rheumatic diseases were registered. Of these, 82 were due to primary rheumatic diseases. Systemic lupus erythematosus, rheumatoid arthritis and vasculitis were the main diagnoses and the mean hospital stay was 18.5 days. Sixty three patients required a consultation with the Rheumatology team specially due to osteoarthritis and crystal induced diseases. Conclusions: Admissions due to rheumatic diseases are prolonged, correspond to 0.46 per cent of all admissions and the main responsible disease is systemic lupus erythematosus


Subject(s)
Humans , Female , Male , Adolescent , Adult , Middle Aged , Arthritis, Rheumatoid/epidemiology , Hospitalization/statistics & numerical data , Lupus Erythematosus, Systemic/epidemiology , Arthritis, Rheumatoid/diagnosis , Arthritis, Rheumatoid/therapy , /statistics & numerical data , Lupus Erythematosus, Systemic/diagnosis , Lupus Erythematosus, Systemic/therapy , Length of Stay/statistics & numerical data
12.
Bol. Hosp. San Juan de Dios ; 37(6): 398-401, nov.-dic. 1990. tab
Article in Spanish | LILACS | ID: lil-96757

ABSTRACT

El presente estudio se emprendió con el propósito de describir las características clínicas y epidemiológicas de los consultantes por accientes, menores de 15 años, en un Servicio de Urgencia Urbano. La información se obtuvo de una muestra de consultas de 10 días elegidos al azar, dentro del período comprendido entre el 1- de septiembre de 1988 al 31 de agosto de 1989. Se obtuvo así un total de 3.941 consultas de las cuales el 17% correspondieron a accidentes. Se observó un predominio del sexo masculino (59%), así como el hecho que la menor proporción de accidentes se encuentra en el grupo de menores de un año. El lugar de la ocurrencia del accidente no se consignó en el 91%. Las lesiones más frecuentes en todos los grupos de edad fueron las contusiones. Las fracturas y mordeduras fueron más comunes en los hombres, en tanto que las contusiones lo fueron en las mujeres. Las lesiones fueron de pronóstico leve, en el 60% de los casos y el 90% de los pacientes pudieron retornar a sus domicilios sin necesidad de ser hospitalizados. Se destaca la importancia de las medidas preventivas, como así mismo la necesidad de mejorar la calidad de la atención de urgencia en los Servicios de Salud estatales que benefician un porcentaje importante de la población del país


Subject(s)
Infant , Child, Preschool , Child , Adolescent , Humans , Male , Female , Emergency Service, Hospital/statistics & numerical data , Poisoning/epidemiology , Wounds and Injuries/epidemiology , Accident Prevention , Accidents/epidemiology , Urban Population
SELECTION OF CITATIONS
SEARCH DETAIL